Presentation TCT 2025 Commentary Presenter: Bernard Prendergast October 27, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study Presenter: David J. Cohen October 27, 2025 More slides + Presentation TCT 2025 Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial Presenter: Evald H. Christiansen October 27, 2025 Presentation TCT 2025 Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial Presenter: Chao Gao October 27, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study Presenter: David J. Cohen October 27, 2025
Presentation TCT 2025 Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial Presenter: Evald H. Christiansen October 27, 2025
Presentation TCT 2025 Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial Presenter: Chao Gao October 27, 2025